Lastly, while use of antiandrogen within 30 days of initiation of leuprorelin treatment was identified as a statistically significant covariate affecting drug-killing effect on leuprorelin-sensitive PSA producing tumor cells, it had minimum effect on PSA progression in our simulation. Here, KLK3 is linked to neoplasm.